Evaluation of Pharmaceutical Care in Depressed Outpatients

Not Applicable

• Conditions: Depression
• Interventions: Procedure: pharmacotherapeutic follow-up

• Registration Number: NCT01571973
• Lead Sponsor: Federal University of São Paulo

Brief Summary

The study examines whether pharmacotherapeutic follow-up improves outcomes of treatment of depressed outpatients.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-03
• Status Verified: 2011-06
• Primary Completion: 2012-03
• Study First Submitted: 2012-04-03
• Study First Submitted QC: 2012-04-04
• Last Update Submitted: 2012-04-04
• Study First Posted: 2012-04-05
• Last Update Posted: 2012-04-05
• Study Completion: 2012-05

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• women between 18 and 65 years, with diagnostic hypothesis of depression at the beginning of treatment or change in treatment unless 2 months (dosage or substance)

Exclusion Criteria

• record of dependence on psychoactive substances, diagnosed schizophrenia,
• low education (illiterate) or cognitive impairment evident that compromise the completion of research instruments

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
intervention group	pharmacotherapeutic follow-up	outpatients receiving pharmaceutical care or pharmacotherapeutic follow-up by 6 months

Primary Outcome Measures

Name	Time	Method
depression level	six months	evaluation depression level by Beck scale

Secondary Outcome Measures

Name	Time	Method
anxiety level	6 months	evaluation anxiety level by Beck scale.
compliance	6 months	evaluation antidepressive treatment compliance by Morisky scale